Skip to main content

Fairbairn Emily's Form 4 filing

IN8BIO, Inc. (INAB) · filed Aug 3, 2021

Accession no.
0001209191-21-049368
Filed
Aug 3, 2021, 4:51 PM ET
Trade date
Aug 3, 2021
Filing delay
Same day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market purchases total $1.00M. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Fairbairn EmilyCIK 0001682638Director, 10% Owner
Transcend Partners Opportunity Fund LLCCIK 000183201910% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 3, 2021Common StockCConversionAcquired+83,124––91,336Indirect
Aug 3, 2021Common StockCConversionAcquired+27,706––27,706Indirect
Aug 3, 2021Common StockCConversionAcquired+3,222,485––3,222,485Indirect
Aug 3, 2021Common StockPPurchaseAcquired+100,000$10.00+$1,000,0003,322,485Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 3, 2021Common StockCConversionDisposed−83,124$0.00$00Indirect
Aug 3, 2021Common StockCConversionDisposed−27,706$0.00$00Indirect
Aug 3, 2021Common StockCConversionDisposed−3,222,485$0.00$00Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)